These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18259819

  • 1. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients.
    Hayashi K, Motoyama S, Sugiyama T, Izumi J, Anbai A, Nanjo H, Watanabe H, Maruyama K, Minamiya Y, Koyota S, Koizumi Y, Takasawa S, Murata K, Ogawa J.
    Ann Surg Oncol; 2008 Apr; 15(4):1224-31. PubMed ID: 18259819
    [Abstract] [Full Text] [Related]

  • 2. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, Watanabe H, Maruyama K, Okuyama M, Ogawa J.
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R, Kitajima Y, Yunotani S, Miyazaki K.
    Anticancer Res; 1999 Dec; 19(6C):5515-21. PubMed ID: 10697609
    [Abstract] [Full Text] [Related]

  • 4. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y, Motoyama S, Nanjo H, Ito S, Yoshino K, Sasaki T, Kuribayashi K, Nagaki Y, Imai K, Saito H, Minamiya Y, Ogawa J.
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [Abstract] [Full Text] [Related]

  • 5. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H.
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
    [Abstract] [Full Text] [Related]

  • 6. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
    Gockel I, Schimanski CC, Heinrich C, Wehler T, Frerichs K, Drescher D, von Langsdorff C, Domeyer M, Biesterfeld S, Galle PR, Junginger T, Moehler M.
    BMC Cancer; 2006 Dec 18; 6():290. PubMed ID: 17176471
    [Abstract] [Full Text] [Related]

  • 7. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
    Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Dec 18; 22(5):2635-9. PubMed ID: 12529975
    [Abstract] [Full Text] [Related]

  • 8. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M, Takiuchi H, Kawabe S, Ohta S, Kii T, Kuwakado S, Katsu K.
    Jpn J Clin Oncol; 2007 Sep 18; 37(9):652-7. PubMed ID: 17940077
    [Abstract] [Full Text] [Related]

  • 9. Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells.
    Usami S, Motoyama S, Koyota S, Wang J, Hayashi-Shibuya K, Maruyama K, Takahashi N, Saito H, Minamiya Y, Takasawa S, Ogawa J, Sugiyama T.
    Biochem Biophys Res Commun; 2010 Jan 29; 392(1):4-8. PubMed ID: 20056108
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T, Muto M, Hattori S, Minashi K, Onozawa M, Nihei K, Ishikura S, Ohtsu A, Yoshida S.
    Endoscopy; 2008 Sep 29; 40(9):717-21. PubMed ID: 18773340
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ.
    Ann Surg Oncol; 2007 Dec 29; 14(12):3602-9. PubMed ID: 17896157
    [Abstract] [Full Text] [Related]

  • 12. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
    Makino T, Yamasaki M, Takemasa I, Takeno A, Nakamura Y, Miyata H, Takiguchi S, Fujiwara Y, Matsuura N, Mori M, Doki Y.
    Ann Surg Oncol; 2009 Jul 29; 16(7):2058-64. PubMed ID: 19408050
    [Abstract] [Full Text] [Related]

  • 13. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK, Chan SC, Chang HK, Liu YH, Wu YC, Hsieh MJ, Tseng CK, Liu HP.
    Eur J Surg Oncol; 2009 Mar 29; 35(3):289-94. PubMed ID: 18396384
    [Abstract] [Full Text] [Related]

  • 14. REG Ialpha protein expression in Barrett's esophagus.
    Chinuki D, Amano Y, Ishihara S, Moriyama N, Ishimura N, Kazumori H, Kadowaki Y, Takasawa S, Okamoto H, Kinoshita Y.
    J Gastroenterol Hepatol; 2008 Feb 29; 23(2):296-302. PubMed ID: 18289358
    [Abstract] [Full Text] [Related]

  • 15. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G, Wang Z, Liu XY, Zhang MY, Liu FY.
    Eur J Cardiothorac Surg; 2009 Jan 29; 35(1):1-7. PubMed ID: 18926712
    [Abstract] [Full Text] [Related]

  • 16. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
    Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E.
    Arch Surg; 2009 Mar 29; 144(3):247-54; discussion 254. PubMed ID: 19289664
    [Abstract] [Full Text] [Related]

  • 17. [Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy].
    Zhu S, Zhai F, Yin W.
    Zhonghua Zhong Liu Za Zhi; 1998 Mar 29; 20(2):129-31. PubMed ID: 10920963
    [Abstract] [Full Text] [Related]

  • 18. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 29; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 19. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):348-56. PubMed ID: 19735862
    [Abstract] [Full Text] [Related]

  • 20. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H.
    Ann Surg Oncol; 2009 Feb 01; 16(2):506-14. PubMed ID: 19050962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.